|
|
TTD Drug ID:
DNC004125
Drug
Information |
Name | 3-(2-Amino-propyl)-1H-indol-5-ol | 5-hydroxy-alpha-methyltryptamine | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C11H14N2O/c1-7(12)4-8-6-13-11-3-2-9(14)5-10(8)11/h2-3,5-7,13-1 4H,4,12H2,1H3 | InChIKey | LYPCGXKCQDYTFV-UHFFFAOYSA-N | Canonical SMILES | CC(CC1=CNC2=C1C=C(C=C2)O)N | Target | Serotonin 1a (5-HT1a) receptor |  | Inhibitor | [1] | Serotonin 2a (5-HT2a) receptor |  | Inhibitor | [2] | Serotonin 2b (5-HT2b) receptor |  | Inhibitor | [2] | Serotonin 2c (5-HT2c) receptor |  | Inhibitor | [2] | Ref 1 | J Med Chem. 2003 Sep 11;46(19):4188-95.A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole. To Reference | Ref 2 | J Med Chem. 2006 Jan 12;49(1):318-28.1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|